Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity

Table 1 TStrC were isolated and propagated from eleven patients.

Sample number	Tumour	Age at resection	Chemotherapy prior to surgery
1	Neuroblastoma	2 years	NB04 Trial Protocol
2	Neuroblastoma	11 years	NB04 Trial Protocol
3	Neuroblastoma	4 months	NB04 Trial Protocol
4	Neuroblastoma	4 years	NB04 Trial Protocol
5	Neuroblastoma	3 months	NB04 Trial Protocol
6	Teratoma	1 month	No prior treatment
7	Osteosarcoma	17 years	COSS96 Trial Protocol
8	Osteosarcoma	20 years	Euramos 1 Trial Protocol
9	Ewing sarcoma	16 years	Euro-Ewing 99 Trial Protocol
10	Rhabdomyosarcoma	16 years	CWS IV 2004 Trial Protocol
11	Rhabdomyosarcoma	8 years	CWS IV 2004 Trial Protocol

ISSN: 1471-2407